📰 Device Designation News
Page 17 - Device Designation News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Device Designation. Real-time updates on events, politics, business and more.
May 24, 2022
Developed in collaboration with Janssen and Mayo Clinic, this technology has the potential to aid physicians in earlier detection of pulmonary hypertension, a progressive, life-threatening disease
May 24, 2022
Also: Anumana receives FDA Breakthrough Device Designation for its ECG-based algorithm designed for early detection of pulmonary hypertension, and AI-enabled imaging companies Aidoc and Gleamer partner.
May 18, 2022
Exactech, a developer and producer of innovative implants, instrumentation, and smart technologies for joint replacement surgery, announced that the U.S. Food and Drug Administration (FDA) has granted a Breakthrough Device Designation for JointMedica’s Polymotion® Hip Resurfacing System. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220517005313/en/ Exactech Announces FDA Breakthrough Device Designation for
May 12, 2022
Also: Wysa receives FDA Breakthrough Device Designation for its mental health chatbot, and Pear Therapeutics expands its telehealth partnership program.
May 10, 2022
SI-BONE, Inc. (NASDAQ:NASDAQ:SIBN) Q1 2022 Earnings Conference Call May 09, 2022, 04:30 PM ET Company Participants Matt Basco - IR, Gilmartin Group Laura Francis - Chief Executive Officer...
May 10, 2022
San Francisco, CA (PRWEB) May 10, 2022 -- Amprion announces the National Institute of Neurological Disorders and Stroke (NINDS) has awarded an additional
May 9, 2022
Cognito Therapeutics Joins Digital Medicine Society’s (DiMe) Alzheimer's Disease and Related Dementias Project to Advance Next-Generation Clinical Measures - read this article along with other careers information, tips and advice on BioSpace
May 5, 2022
Under the deal, MedRhythms would receive a $3 million upfront payment and could earn up to $117.5 million if certain milestones are met.
April 26, 2022
Coming nearly two years after the company's $100 million Series C, Biofourmis tallied its total raise at $445 million.
April 20, 2022
With the partnership, doulas will be able to refer their Medicaid patients to Brave for mental health services like therapy, psychiatry and medication management.